Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2021

May 05, 2021

SELL
$242.95 - $284.63 $102,039 - $119,544
-420 Closed
0 $0
Q4 2020

Feb 04, 2021

SELL
$236.26 - $355.63 $2,362 - $3,556
-10 Reduced 2.33%
420 $103,000
Q1 2020

Apr 22, 2020

SELL
$268.85 - $341.04 $67,750 - $85,942
-252 Reduced 36.95%
430 $136,000
Q3 2019

Nov 07, 2019

BUY
$217.44 - $243.88 $53,707 - $60,238
247 Added 56.78%
682 $159,000
Q2 2019

Aug 16, 2019

BUY
$219.29 - $241.72 $19,516 - $21,513
89 Added 25.72%
435 $102,000
Q1 2019

May 14, 2019

BUY
$216.71 - $338.96 $2,383 - $3,728
11 Added 3.28%
346 $82,000
Q4 2018

Feb 14, 2019

BUY
$278.5 - $352.75 $93,297 - $118,171
335 New
335 $101,000

Others Institutions Holding BIIB

About BIOGEN INC.


  • Ticker BIIB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 144,000,992
  • Market Cap $25B
  • Description
  • Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...
More about BIIB
Track This Portfolio

Track Human Investing LLC Portfolio

Follow Human Investing LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Human Investing LLC, based on Form 13F filings with the SEC.

News

Stay updated on Human Investing LLC with notifications on news.